摘要
目的:比较应用左旋多巴和同时应用多巴胺受体激动剂治疗帕金森病(PD)的成本效果。方法:300例PD病人根据应用药物分为两组,分别为左旋多巴治疗组和多巴胺受体激动剂治疗组。对两组病人进行UPDRS评分,同时调查治疗费用,治疗费用分为直接费用和间接费用。追踪时间为两年。结果:两组治疗两年后UPDRS评分和治疗总成本均有差异(P<0.05)。结论:应用多巴胺受体激动剂治疗PD具有较高的成本效果比。
Objective： To evaluate the cost-effectiveness of PD＇s pharmacotherapy with L-dopa and Dopamine Agonist. Methods：300 patients with PD were divided into 2 groups. Group A was treated with L-dopa and group B with Dopamine Agonist for two years. Apply UPDRS scale to evaluate treatment outcome and investigate the cost at the same time. Results： There were different between L-dopa and Dopamine Agonist treatment on UPDRS scale and total cost. Conclusions： Applying Dopamine Agonist to treat PD have a high cost- effectiveness.
出处
《中国医药导刊》
2009年第6期1023-1023,1025,共2页
Chinese Journal of Medicinal Guide
